We are live on
!
Find out more
PCM
Palouse Capital Management Portfolio holdings
AUM
$160M
1-Year Est. Return
36.15%
This Fund
S&P 500
This Quarter
Est. Return
+2.71%
1 Year Est. Return
+36.15%
3 Year Est. Return
+67.75%
5 Year Est. Return
+68.17%
10 Year Est. Return
+160.38%
AUM
$286M
AUM Growth
-$9.11M
(-3.1%)
Cap. Flow
-$15.6M
Cap. Flow
% of AUM
-5.45%
Top 10 Holdings %
Top 10 Hldgs %
25.93%
Holding
116
New
14
Increased
46
Reduced
45
Closed
10
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco
IVZ
|
+$8.43M |
| 2 |
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$6.91M |
| 3 |
Molson Coors Class B
TAP
|
+$4.98M |
| 4 |
NXP Semiconductors
NXPI
|
+$2.09M |
| 5 |
State Street SPDR Bloomberg High Yield Bond ETF
JNK
|
+$745K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$8.31M |
| 2 |
Eaton
ETN
|
+$6.34M |
| 3 |
Amgen
AMGN
|
+$6.25M |
| 4 |
Welltower
WELL
|
+$4.79M |
| 5 |
Target
TGT
|
+$4.39M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.86% |
| 2 | Technology | 15.06% |
| 3 | Healthcare | 13.13% |
| 4 | Industrials | 9.71% |
| 5 | Consumer Discretionary | 8.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Prudential Financial
PRU
$42.7B
| $9.12M | 3.18% |
89,969
-305
| -0.3% | -$30.1K |
|
2
Microsoft
MSFT
$3.62T
| $7.78M | 2.72% |
68,061
-1,469
| -2% | -$159K |
|
|
3
Invesco
IVZ
$13.6B
| $7.72M | 2.7% |
+337,299
| New | +$8.43M |
|
4
BP
BP
$114B
| $7.67M | 2.68% |
174,161
-5,224
| -3% | -$218K |
|
5
Wells Fargo
WFC
$266B
| $7.49M | 2.62% |
142,564
-2,105
| -1% | -$120K |
|
6
Gilead Sciences
GILD
$163B
| $7.14M | 2.5% |
92,498
+456
| +0.5% | +$34.4K |
|
|
IPG
7
DELISTED
Interpublic Group of Companies
IPG
| $7.13M | 2.49% |
311,635
-1,188
| -0.4% | -$26.9K |
|
|
8
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$46.9B
| $6.92M | 2.42% |
+75,529
| New | +$6.91M |
|
9
AT&T
T
$162B
| $6.65M | 2.32% |
262,279
-2,544
| -1% | -$62.3K |
|
10
Cisco
CSCO
$457B
| $6.61M | 2.31% |
135,958
-1,272
| -0.9% | -$57.2K |
|
11
CVS Health
CVS
$134B
| $6.58M | 2.3% |
83,641
-610
| -0.7% | -$43.6K |
|
12
Huntington Bancshares
HBAN
$35.1B
| $6.58M | 2.3% |
440,829
-4,027
| -0.9% | -$63K |
|
13
Johnson Controls International
JCI
$88.7B
| $6.36M | 2.22% |
181,640
-3,472
| -2% | -$128K |
|
14
KLA
KLAC
$239B
| $6.22M | 2.17% |
611,110
-6,350
| -1% | -$69.4K |
|
15
J.M. Smucker
SJM
$12.6B
| $6.2M | 2.17% |
60,463
-841
| -1% | -$91.8K |
|
16
AbbVie
ABBV
$433B
| $6.19M | 2.16% |
65,463
-393
| -0.6% | -$37.3K |
|
17
Intel
INTC
$459B
| $6.19M | 2.16% |
130,816
+2,551
| +2% | +$124K |
|
|
18
Molson Coors Class B
TAP
$7.86B
| $6.08M | 2.12% |
98,853
+75,315
| +320% | +$4.98M |
|
19
International Paper
IP
$21.9B
| $5.56M | 1.94% |
119,503
-262
| -0.2% | -$13K |
|
20
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.6B
| $5.55M | 1.94% |
70,959
+368
| +0.5% | +$28.8K |
|
21
MetLife
MET
$62B
| $5.51M | 1.93% |
117,997
-288
| -0.2% | -$13.2K |
|
22
iShares Preferred and Income Securities ETF
PFF
$13.3B
| $5.5M | 1.92% |
148,047
-1,135
| -0.8% | -$42.6K |
|
|
23
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$6.9B
| $5.15M | 1.8% |
47,660
+6,932
| +17% | +$745K |
|
24
FedEx
FDX
$73.2B
| $5.05M | 1.77% |
20,983
-100
| -0.5% | -$24.2K |
|
25
Carnival Corporation Ltd
CCL
$39.4B
| $4.58M | 1.6% |
71,822
+55
| +0.1% | +$3.34K |
|
Similar funds
MWM
PCC
CF
SGCM
RCWM
LCA
WHCI
FPWM
Palouse Capital Management's Q3 2018 Portfolio in Review
As of Q3 2018, Palouse Capital Management held 116 positions worth $286M, down 3.1% from $295M the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Palouse Capital Management withdrew a net $15.6M in Q3 2018, closing 10 positions and reducing 45 holdings. Its most notable exit was Pfizer, an estimated $8.31M position sold in full.
By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 15% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Palouse Capital Management opened a new position in Invesco worth $7.72M.
- Palouse Capital Management's largest Q3 2018 buy was Invesco: 337,299 shares worth $7.72M.
- Palouse Capital Management added most to Molson Coors Class B in Q3 2018, an estimated $4.98M increase.
- Palouse Capital Management's biggest Q3 2018 reduction was Nucor, cutting an estimated $3.25M.
- Palouse Capital Management fully exited Pfizer in Q3 2018, selling an estimated $8.31M.
- Palouse Capital Management's ten largest holdings make up 26% of its $286M portfolio in Q3 2018.
- Palouse Capital Management opened 14 new positions and closed 10 in Q3 2018.
- Palouse Capital Management's portfolio value fell 3.1% quarter-over-quarter to $286M.
Based on Palouse Capital Management's 13F filing for Q3 2018, filed 29 Oct 2018.